Tower Research Capital LLC (Trc) Portage Biotech Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.73 - $3.87 $10,453 - $14,818	3,829 Added 147.21%	6,430 $22,000
Q1 2023 May 09, 2023	SELL	$2.6 - $7.2 $629 - $1,742	-242 Reduced 8.51%	2,601 $8,000
Q4 2022 Feb 10, 2023	BUY	$4.42 - $150.6 $8,265 - $281,622	1,870 Added 192.19%	2,843 $15,000
Q3 2022 Nov 10, 2022	BUY	$6.81 - $136.4 $3,731 - $74,747	548 Added 128.94%	973 $7,000
Q2 2022 Aug 15, 2022	SELL	$5.16 - $11.95 $7,198 - $16,670	-1,395 Reduced 76.65%	425 $3,000
Q1 2022 May 12, 2022	BUY	$6.57 - $12.0 $6,543 - $11,952	996 Added 120.87%	1,820 $12,000
Q4 2021 Feb 14, 2022	BUY	$10.73 - $23.74 $4,656 - $10,303	434 Added 111.28%	824 $9,000
Q3 2021 Nov 15, 2021	SELL	$13.65 - $22.4 $6,879 - $11,289	-504 Reduced 56.38%	390 $8,000
Q2 2021 Aug 16, 2021	BUY	$20.96 - $42.81 $7,587 - $15,497	362 Added 68.05%	894 $19,000
Q1 2021 May 17, 2021	BUY	$17.55 - $39.5 $9,336 - $21,014	532 New	532 $15,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $83M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.